Atazanavir Capsules
FreeAtazanavir capsules are protease inhibitor antiretroviral medications used to treat HIV-1 infection. They are typically available in strengths of 150 mg, 200 mg, and 300 mg.
Didanosine Capsules
FreeDidanosine capsules, often known by the brand name Videx EC, are delayed-release antiretroviral medications used to treat HIV. They are specifically formulated as enteric-coated beadlets within a capsule to prevent the active medicine from being destroyed by stomach acid.
Dolutegravir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Polymorphically Stabilized Microdose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the Dolutegravir Sodium salt.
Active Ingredient Strength Primary Clinical Function Dolutegravir (as Sodium) USP/Ph.Eur. 50 mg The Global INSTI Anchor: The definitive therapeutic payload required to force immediate, systemic viral suppression and maintain an undetectable viral load. Excipients D-Mannitol / Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Sodium Stearyl Fumarate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing strict low-moisture granulation to prevent the active Dolutegravir Sodium from undergoing polymorphic shifts during compression, guaranteeing absolute pharmacokinetic bioequivalence) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).
Efavirenz ,Emtricitabine & Tenofovir Disoproxil Fumarate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Mega-Dose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles to ensure the absolute chemical survival of the moisture-sensitive Tenofovir and light-sensitive Efavirenz.
Active Ingredient Strength Primary Clinical Function Efavirenz USP/Ph.Eur. 600 mg The NNRTI Anchor: The massive, highly lipophilic non-nucleoside payload required to force immediate, systemic viral suppression. Emtricitabine (FTC) USP/Ph.Eur. 200 mg The Cytidine Analogue: Provides profound, long-acting intracellular viral suppression to reinforce the backbone. Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur. 300 mg The Nucleotide Backbone: The heavy-hitting chain terminator required to completely halt viral DNA elongation. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Hydroxypropyl Cellulose / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Surfactant / Heavy Film-Coating (Engineered utilizing High-Compression Bi-Layer Technology to fuse 1,100mg of active API into a single, aerodynamically shaped tablet that remains easy for patients to swallow, heavily coated to lock out destructive tropical humidity) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).
Efavirenz Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the highly lipophilic active ingredient.
Active Ingredient Strength Primary Clinical Function Efavirenz USP/Ph.Eur. 600 mg The Global NNRTI Macrodose: The massive therapeutic payload required to force immediate, systemic viral suppression when combined with a dual-NRTI backbone. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Surfactant / Binder / Heavy Film-Coating (Engineered specifically utilizing powerful surfactants like Sodium Lauryl Sulfate to drastically increase the solubility of the notoriously lipophilic Efavirenz molecule, ensuring rapid and complete gastrointestinal absorption) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).
Emtricitabine & Tenofovir Disoproxil Fumarate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the moisture-sensitive Tenofovir.
Active Ingredient Strength Primary Clinical Function Emtricitabine (FTC) USP/Ph.Eur. 200 mg The Cytidine Analogue: Provides profound, long-acting intracellular viral suppression with an exceptionally favorable safety profile. Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur. 300 mg
(Eq. to 245 mg Tenofovir Disoproxil)The Nucleotide Backbone: The heavy-hitting reverse transcriptase inhibitor required to anchor the ARV regimen and prevent viral breakthrough. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Lactose Monohydrate / Magnesium Stearate / Premium Polymeric Film (Opadry) Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing dry-granulation and heavy film-coating to protect the API from atmospheric moisture, ensuring the massive 500mg active payload remains structurally intact and easily swallowable) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).
Lamivudine Tablets
FreeProduct Composition & Available Portfolio strengths
We manufacture Lamivudine across the precise compendial strengths mandated to manage either targeted chronic hepatic monotherapy or high-potency systemic combination antiretroviral protocols.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lamivudine USP / BP / IP 100 mg Oral Solid Film-Coated Tablet Chronic Hepatitis B (HBV): Low-dose configuration optimized for standalone daily suppression of active hepatic viral replication. Lamivudine USP / BP / IP 150 mg Oral Solid Film-Coated Tablet Standard Antiretroviral (HIV): Baseline strength designed for twice-daily co-administration or integration into standard multi-drug ARV regimens. Lamivudine USP / BP / IP 300 mg Oral High-Potency Solid Tablet High-Compliance Antiretroviral (HIV): Standard adult once-daily high-dose format engineered to optimize long-term patient compliance. Lopinavir & Ritonavir Tablet
FreeProduct Composition & Strength
We supply this product as Film Coated Tablets (typically Yellow, Oval). The proprietary matrix ensures high bioavailability of poorly soluble Lopinavir.
Active Ingredient Strength (Standard) Therapeutic Role Lopinavir USP/BP 200 mg HIV-1 Protease Inhibitor Ritonavir USP/BP 50 mg Pharmacokinetic Booster (Pediatric Variant) 100 mg Lopinavir + 25 mg Ritonavir Pediatric HIV Management Excipients Q.S. Copovidone / Sorbitan Monolaurate / Silica Solubility Enhancers Stavudine Capsules
FreeStavudine capsules are antiretroviral medications, specifically nucleoside reverse transcriptase inhibitors (NRTIs), used in the treatment of HIV-1 infection. They are available in strengths of 15 mg, 20 mg, 30 mg, and 40 mg
Tenofovir Tablets
FreeAbivir
Tenofovir Disoproxil Fumarate Tablet 300 mg
Each Film Coated Tablet Contains:
Tenofovir Disoproxil Fumarate 300 mgUsage: – help control HIV infection
Category: – HIV Anti viral drugs
Therapeutic category: – Antiviral, Anti HIV
Pcd marketing:-
Manufacturer: – Healthy Life Pharma Pvt Ltd
Exporter: – Healthy Inc
Supplier: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Distributor: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Seller: – Healthy Life Pharma Pvt Ltd
Healthy Inc
Zidovudine Capsules
FreeZidovudine capsules, also known by the brand name Retrovir or the abbreviation AZT, are antiretroviral medications used to treat HIV-1 infection and prevent maternal-fetal transmission.
Showing all 11 results




